|
1
|
American Cancer Society, . Key statistics for endometrial cancer. Journal. 2018.
|
|
2
|
World Cancer Research Fund International, . Endometrial cancer (cancer of the lining of the womb) statistics. Journal. 2018.
|
|
3
|
American Cancer Society, . Cancer facts & figures 2015. https://oralcancerfoundation.org/wp-content/uploads/2016/03/Us_Cancer_Facts.pdf
|
|
4
|
Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet. 366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bansal N, Yendluri V and Wenham RM: The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 16:8–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baiden-Amissah REM, Annibali D, Tuyaerts S and Amant F: Endometrial cancer molecular characterization: The key to identifying high-risk patients and defining guidelines for clinical decision-making? Cancers (Basel). 13:39882021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network, ; Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, et al: Integrated genomic characterization of endometrial carcinoma. Nature. 497:67–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Welch DR and Hurst DR: Defining the hallmarks of metastasis. Cancer Res. 79:3011–3027. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurra V, Krajewski KM, Jagannathan J, Giardino A, Berlin S and Ramaiya N: Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging. 13:113–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ridley AJ: Rho GTPase signalling in cell migration. Curr Opin Cell Biol. 36:103–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goubran HA, Kotb RR, Stakiw J, Emara ME and Burnouf T: Regulation of tumor growth and metastasis: The role of tumor microenvironment. Cancer Growth Metastasis. 7:9–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cirri P and Chiarugi P: Cancer associated fibroblasts: The dark side of the coin. Am J Cancer Res. 1:482–497. 2011.PubMed/NCBI
|
|
14
|
Dvorak HF: Tumors: Wounds that do not heal-redux. Cancer Immunol Res. 3:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subramaniam KS, Tham ST, Mohamed Z, Woo YL, Mat Adenan NA and Chung I: Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. PLoS One. 8:e689232013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jain P, Worthylake RA and Alahari SK: Quantitative analysis of random migration of cells using time-lapse video microscopy. J Vis Exp. e35852012.PubMed/NCBI
|
|
19
|
Vega FM, Fruhwirth G, Ng T and Ridley AJ: RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol. 193:655–665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T and Zare P: Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 18:592020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C and Marini FC: Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 18:842016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi Y, Inoue S, Takahashi M, Hata T and Muramatsu M: Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res. 7:3097–3105. 2001.PubMed/NCBI
|
|
23
|
Teng F, Tian WY, Wang YM, Zhang YF, Guo F, Zhao J, Gao C and Xue FX: Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis. J Hematol Oncol. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M, et al: Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. J Pathol. 248:51–65. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, et al: Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 33:463–479.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Subramaniam KS, Omar IS, Kwong SC, Mohamed Z, Woo YL, Mat Adenan NA and Chung I: Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. Am J Cancer Res. 6:200–213. 2016.PubMed/NCBI
|
|
27
|
Arnold JT, Lessey BA, Seppälä M and Kaufman DG: Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res. 62:79–88. 2002.PubMed/NCBI
|
|
28
|
Shi M, Zhang H, Li M, Xue J, Fu Y, Yan L and Zhao X: Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro. Gynecol Oncol. 123:387–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo N, Guan Q, Zheng L, Qu X, Dai H and Cheng Z: Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res. 163:232–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pineda MJ, Lu Z, Cao D and Kim JJ: Influence of cancer-associated endometrial stromal cells on hormone-driven endometrial tumor growth. Horm Cancer. 6:131–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang B, Chen R, Liang X, Shi J, Wu X, Zhang Z and Chen X: Estrogen enhances endometrial cancer cells proliferation by upregulation of prohibitin. J Cancer. 10:1616–1621. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim SA, Lee EK and Kuh HJ: Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. Exp Cell Res. 335:187–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ and Feng YM: Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling. Br J Cancer. 110:724–732. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baulida J: Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts. Mol Oncol. 11:847–859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gaggioli C: Collective invasion of carcinoma cells: When the fibroblasts take the lead. Cell Adh Migr. 2:45–47. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Däster S, Amatruda N, Calabrese D, Ivanek R, Turrini E, Droeser RA, Zajac P, Fimognari C, Spagnoli GC, Iezzi G, et al: Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment. Oncotarget. 8:1725–1736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Riffle S and Hegde RS: Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J Exp Clin Cancer Res. 36:1022017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A and Tesei A: 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Sci Rep. 6:191032016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Choe C, Shin YS, Kim SH, Jeon MJ, Choi SJ, Lee J and Kim J: Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway. Anticancer Res. 33:3715–3723. 2013.PubMed/NCBI
|
|
40
|
Henriksson ML, Edin S, Dahlin AM, Oldenborg PA, Öberg Å, Van Guelpen B, Rutegård J, Stenling R and Palmqvist R: Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am J Pathol. 178:1387–1394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Angelucci C, Lama G, Proietti G, Fabbri C, Masetti R, Sica S and Maulucci G: Breast cancer cells and fibroblasts in co-culture: Reciprocal influences on cell adhesion, membrane fluidity and migration. Ital J Anat Embryol. 116:122011.
|
|
42
|
Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS and Friedl P: Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol. 9:893–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Djamgoz MB, Coombes RC and Schwab A: Ion transport and cancer: From initiation to metastasis. Philos Trans R Soc Lond B Biol Sci. 369:201300922014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
MacDonald IC, Groom AC and Chambers AF: Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. Bioessays. 24:885–893. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Spiering D and Hodgson L: Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr. 5:170–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu J, Gao HY and Wang XF: The role of the Rho/ROCK signaling pathway in inhibiting axonal regeneration in the central nervous system. Neural Regen Res. 10:1892–1896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chiba Y, Goto K, Momata M, Kobayashi T and Misawa M: Induction of RhoA gene expression by interleukin-4 in cultured human bronchial smooth muscle cells. J Smooth Muscle Res. 46:217–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiba Y, Nakazawa S, Todoroki M, Shinozaki K, Sakai H and Misawa M: Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am J Respir Cell Mol Biol. 40:159–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Villar-Cheda B, Dominguez-Meijide A, Joglar B, Rodriguez-Perez AI, Guerra MJ and Labandeira-Garcia JL: Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiol Dis. 47:268–279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yoneda A, Multhaupt HA and Couchman JR: The Rho kinases I and II regulate different aspects of myosin II activity. J Cell Biol. 170:443–453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X and Surks HK: ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res. 104:531–540. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Matsubara M and Bissell MJ: Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context. Oncotarget. 7:31602–31622. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Anderson S, DiCesare L, Tan I, Leung T and SundarRaj N: Rho-mediated assembly of stress fibers is differentially regulated in corneal fibroblasts and myofibroblasts. Exp Cell Res. 298:574–583. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kolega J: Cytoplasmic dynamics of myosin IIA and IIB: Spatial ‘sorting’ of isoforms in locomoting cells. J Cell Sci. 111:2085–2095. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M and Narumiya S: Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol. 57:976–983. 2000.PubMed/NCBI
|
|
57
|
Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H and Araie M; K-115 Clinical Study Group, : Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115. JAMA Ophthalmol. 131:1288–1295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Okumura N, Kinoshita S and Koizumi N: Application of Rho kinase inhibitors for the treatment of corneal endothelial diseases. J Ophthalmol. 2017:26469042017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mueller BK, Mack H and Teusch N: Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov. 4:387–398. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Garnock-Jones KP: Ripasudil: First global approval. Drugs. 74:2211–2215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 9:1392–1400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Rodriguez-Hernandez I, Cantelli G, Bruce F and Sanz-Moreno V: Rho, ROCK and actomyosin contractility in metastasis as drug targets. F1000Res 5 (F1000 Faculty Rev). 7832016. View Article : Google Scholar
|
|
63
|
Liu S, Goldstein RH, Scepansky EM and Rosenblatt M: Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 69:8742–8751. 2009. View Article : Google Scholar : PubMed/NCBI
|
